Chong Kun Dang Pharmaceutical Corp. (185750-KS) Stock Split, History Data
Working capital analysis
In terms of working capital, Chong Kun Dang Pharmaceutical Corp. maintains a healthy position.
The total current assets of the company are valued at $946571860795.
This represents a growth rate of 32.645% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $219646348416, exhibiting a growth rate of 87.065% year-on-year.
The receivables, another significant portion of the current assets, are valued at $311468610303.
The year-on-year growth rate for receivables is 8.410%.
The inventory, which forms a critical part of the assets, is valued at $261431891828.
This represents a healthy year-on-year growth of -3.203%
On the liabilities side, the company's current liabilities total $511465846744.
This reflects a growth rate of 36.678% over the previous year, indicating the company's financial obligations are well under control.
2023
2022
2021
2020
2019
2018
Cash and investments
219646.35
117416.90
131812.68
123659.08
76922.52
45948.69
Receavebles
311468.61
287306.62
234703.74
226958.61
205590.05
216791.70
Inventory
261431.89
270081.46
224722.93
185565.18
148453.69
127590.72
Other
8606.06
365.51
20387.88
25734.89
24718.04
0.00
Total Current Assets
946571.86
713614.78
667147.15
600114.08
471135.03
390331.11
Acc Payable
183938.77
145436.25
129327.40
144120.06
101969.49
68591.98
Short Term Debt
184767.37
124445.50
102091.45
78632.09
92212.97
58577.99
Other Current Liab
134996.55
98922.28
20691.51
20802.70
19255.03
55643.45
Current Liabilities
511465.85
374213.06
320229.87
320620.87
277069.01
204509.19
Capital Structure
When examining the capital structure of Chong Kun Dang Pharmaceutical Corp., it is clear that the company manages a robust portfolio.
These earnings represent the profits that Chong Kun Dang Pharmaceutical Corp. has chosen to reinvest in the business rather than distribute as dividends.
